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Poor quality of biological samples will result in an inaccurate analysis of next-generation sequencing (NGS). Therefore, methods to
accurately evaluate sample integrity are needed. Among methods for evaluating RNA quality, the RNA integrity number equivalent
(RINe) is widely used, whereas the DV200, which evaluates the percentage of fragments of >200 nucleotides, is also used as a quality
assessment standard. In this study, we compared the RINe and DV200 RNA quality indexes to determine the most suitable RNA
index for the NGS analysis. Seventy-one RNA samples were extracted from formalin-fixed paraffin-embedded tissue samples
(n = 30), fresh-frozen samples (n = 25), or cell lines (n = 16). After assessing RNA quality using the RINe and DV200, we
prepared two kinds of stranded mRNA sequencing libraries. Finally, we calculated the correlation between each RNA quality
index and the amount of library product (1st PCR product per input RNA). The DV200 measure showed stronger correlation
with the amount of library product than the RINe (R2 = 0:8208 for the DV200 versus 0.6927 for the RINe). Receiver operating
characteristic curve analyses revealed that the DV200 was the better marker for predicting efficient library production than the
RINe using a threshold of >10 ng/ng for the amount of the 1st PCR product per input RNA (cutoff value for the RINe and
DV200, 2.3 and 66.1%; area under the curve, 0.99 and 0.91; sensitivity, 82% and 92%; and specificity, 93% and 100%,
respectively). Our results indicate that NGS libraries prepared using RNA samples with the DV200 value > 66:1% exhibit greater
sensitivity and specificity than those prepared with the RINe values > 2:3. These findings suggest that the DV200 is superior to
the RINe, especially for low-quality RNA, because it is a more consistent assessment of the amount of the 1st NGS library
product per input.
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1. Introduction
Next-generation sequencing (NGS) has become an essential
technology in molecular biology research and clinical assess-
ment [1–3]. However, the quality of the input biological sam-
ples has a critical effect on NGS results. It is important to
grasp the quality of NGS results before conducting NGS anal-
yses in order to avoid wasting precious samples and to min-
imize cost and labor.
Several RNA quality indexes have been developed, includ-
ing RNA integrity number equivalent (RINe) andDV200met-
rics (percentage of RNA fragments > 200 nucleotides in size).
RINe is generally and widely used for assessing RNA integrity,
and it is based on a mathematical model that calculates an
objective quantitative measurement of RNA degradation that
represents the relative ratio of signal in the fast zone to the
18S peak signal.
The DV200 was developed by Agilent in 2014 as a tool to
more accurately assess the quality of RNA samples (http://
urx.red/OB4Y) and used as an RNA quality assessment stan-
dard even in the protocol published by Illumina. Values
indicative of high quality can be obtained with the DV200
even for samples exhibiting weak 18S and 28S peaks if there
is a sufficient volume of RNA fragments greater than 200nt
in length. However, the best practice for evaluating RNA
quality remains uncertain. In this study, we compared the
two RNA quality indexes in terms of the amount of the 1st
PCR product as preparation for NGS analyses in order to
determine a much more suitable RNA quality index.
2. Materials and Methods
2.1. Data Collection. Seventy-one specimens were obtained at
four sections of Okayama University Hospital (Center for
Clinical Oncology; Department of Hematology, Oncology
and Respiratory Medicine; Department of Respiratory Med-
icine; and Department of Thoracic, Breast and Endocri-
nological Surgery) during their own studies. All study
protocols were approved by the Institutional Review Boar-
d/Ethical Committee of Okayama University, Okayama,
Japan (reference numbers K1603-066, K1512-024, K1505-
033, K1605-022, and K1808-009), and all participants signed
written informed consent. Each section consigned an analysis
by NGS to our biobank for its own research purpose and
provided collected samples to Okayama University Hospital
Biobank. This study uses only the data obtained in the steps
of RNA extraction from the provided collected samples,
preparation of the NGS library, and the NGS analysis, which
were conducted at Okayama University Hospital Biobank.
Detailed information regarding each of the samples used in
the study is shown in Supplemental Table 1.
2.2. RNA Extraction and Quality Evaluation. RNA was
extracted from frozen samples (n = 25) and cell lines (n = 16)
using the RNeasy Mini kit (Qiagen, Hilden, Germany) or
from formalin-fixed paraffin-embedded (FFPE) tissue sam-
ples (n = 30) using the RNeasy FFPE kit. RINe values were
automatically determined on the basis of electropherograms
generated using TapeStation HS RNA ScreenTape (Agilent
Technologies, Santa Clara, CA, USA). We calculated the
DV200 values on the basis of the same electropherograms
using TapeStation Analysis software.
2.3. NGS Library Construction. NGS libraries were prepared
using TruSeq RNA Access (Illumina, San Diego, CA, USA)
(n = 63) or TruSight RNA Pan-Cancer (Illumina, San Diego,
CA, USA) (n = 8). The NGS library preparation kits utilized
the same workflows: fragmentation, cDNA synthesis, 1st
PCR, hybridization, 2nd PCR, and cleanup, although hybrid-
ization probes were different. The amount of the NGS library
product was quantified using a Qubit 2.0 fluorometer
(Thermo Fisher, Waltham, MA, USA).
2.4. Receiver Operating Characteristic Curve Analysis. We
generated receiver operating characteristic (ROC) curves
using JMP 9.0.2 software (SAS Institute Japan, Osaka, Japan).
We determined >10 ng/ng for the 1st PCR product per input
RNA as the threshold on the basis of the following factors:
(1) 200 ng of 1st PCR product is needed to proceed to the
2nd PCR step for the NGS library preparation and (2) the
minimum recommended input volume of RNA is 20 ng, as
determined according to the following formula: 200 ng 1st
PCR product/20 ng input volume = 10 ng/ng.
3. Results
3.1. Distribution of RINe and DV200 Values. The median
values (range) were 2.1 (1.0–9.6) for the RINe and 66.1%
(24.6–97.3%) for the DV200. The DV200 values were rela-
tively scattered, whereas the RINe values exhibited two peaks
at approximately 1 to 4 and 8 to 10 (Figures 1(a) and 1(b);
Supplementary Table 1).
3.2. Correlation between DV200 and RINe. As shown in
Figure 1(c), the RINe and DV200 values were correlated
(R2 = 0:6944). It should be noted that 12 of 32 (37.5%) sam-
ples with a low RINe value (<5) exhibited a high DV200 value
(>70%), suggesting that the DV200, compared with RINe,
has the potential to increase the number of samples available
for the following assays.
3.3. RINe and DV200 Values and NGS Library Preparation.
The median of the 1st NGS library product per input was
41.0 ng/μl (0.01–129.5 ng/μl) (Supplemental Table 1). Both
the RINe and DV200 values correlated positively with the
amount of the 1st NGS library product, although the
DV200 exhibited a better correlation than the RINe index
(R2 = 0:8208 versus 0.6927, respectively) (Figures 2(a) and
2(b)). The fresh and FFPE samples were extracted and
analyzed separately from the other samples to investigate
the effects of different sample types. In the fresh samples,
a high RINe value, a high DV200 value, and a sufficient
amount of the 1st NGS library product were obtained
(more than 8.3, 89.32, and 73.15 ng/ng, respectively), even
though the R2 value of the RINe was higher than that of
the DV200 (Figures 2(c) and 2(d)). Although the amount
of the 1st NGS library product was low in all FFPE
samples, the DV200 showed better R2 value than the
RINe (0.0294 versus 0.0006), indicating that the DV200
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is useful for evaluating RNA in low-quality samples such
as FFPE.
3.4. Receiver Operating Characteristic Curve Analyses. The
analysis of ROC curves indicated that the optimal RINe and
DV200 cutoff values were 2.3 and 66.1%, respectively, when
>10 ng/ng for the 1st PCR product per RNA input was con-
sidered a sufficient amount for NGS. The area under the
curve (AUC) for the DV200 was 0.99, with sensitivity of
92% and specificity of 100%, whereas the AUC for the RINe
was 0.91, with sensitivity of 82% and specificity of 93%
(Figures 3(a) and 3(b)).
4. Discussion
Remarkable progress in development of NGS technologies
has made it possible to analyze a variety of specimens, includ-
ing highly degraded materials such as 10-year-old FFPE sam-
ples [4]. The RINe has been widely used as an indicator of
RNA quality in NGS, microarray, and qPCR [5–7]. However,
the DV200 is more suitable than the RINe for quantification
of RNA because it can be applied to evaluate not only RNAs
extracted from fresh or frozen samples but also samples with
lower RINe values, such as RNAs extracted from FFPE sam-
ples [8, 9]. In our study, the DV200 showed better correlation
with the amount of the 1st NGS library product compared
with the RINe even for low-quality samples such as FFPE.
Recently, paraffin-embedded RNA metrics (PERM) is also
proposed as a novel indicator that is based on the intensity
of fluorescence at specific time points using the Agilent
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA)
[10]. Although we attempted to perform a PERM analysis,
unfortunately, the TapeStation used in this study did not
support the PERM analysis.
Furthermore, our study also revealed that the DV200
with a cutoff value of 66.1% provided greater AUC, sensitiv-
ity, and specificity than the RINe (cutoff value 2.3) on the
basis of the analysis of ROC curves. These results indicate
that the DV200 with a cutoff value of 66.1% is more useful
than the RINe for predicting whether a sufficient amount of
high-quality 1st NGS product can be obtained.
In addition to the 1st NGS library product per input, we
examined the effect of RNA quantification on quality metrics
of RNA sequencing (RNA-seq): duplicates, reads notmapped,
and nonspecificmatches. As shown in Supplemental Figure 1,
the DV200 showed betterR2 values than the RINe. Consistent
with our report, another study reported a positive correlation
between the DV200 value and the number of uniquely
mapped NGS reads, which are reads mapped to one region
of the reference genome [11]. By contrast, sample selection
based on the RINe values reportedly provides no advantage
for determining the quality of NGS reads [12]. In order to
analyze some functional relationships between the RNA
quality and the result of RNA-seq, we analyzed the
transcripts per million (TPM) of protein coding genes
(Supplemental Figure 2), and we found that the total TPM
of protein coding genes in all the fresh samples (RINe > 8:0
and DV200 > 89%) exceeds 950,000 (meaning 95% of total
RNA-seq reads). This result suggests that RNA-seq with
high-quality input RNA using TruSeq RNA Access library
preparation protocols could capture the whole picture of
gene expression of protein coding genes with the least
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Figure 1: Relationship between RINe and DV200 values. (a, b) Distribution of RINe and DV200 values. Graphs show the distribution of RINe
and DV200 values categorized in 2-point and 20-point increments, respectively. (c) Correlation between RINe and DV200 values. RINe and
DV200 values were determined using TapeStation 2200.
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information loss. On the other hand, the total TPM of
protein coding genes in all the FFPE samples (RINe < 3:0
and DV200 < 55%) ranged from 675,000 to 778,000
(meaning 67.5–77.8% of total RNA-seq reads) with one
outlier (578,000). This result suggests that RNA-seq for
low-quality input RNA may lead to the gene expression
profiles with some information loss due to the potential
RNA degradation/fragmentation. The total TPM of protein
coding genes in frozen samples ranged widely from 150,000
to 970,000 on the basis of their RNA quality. On the other
hand, in samples with RINe values of 2 or less, some
samples had TPM values of more than 800,000, but others
had TPM values of 800,000 or less. This result suggests that
careful interpretation is required when using RNA with an
RINe value of 2 or less.
These data suggest that the DV200 index is superior to
RINe for assessing RNA integrity in order to obtain NGS
results worthy of evaluation.
In general, the time required for tissue acquisition, fixa-
tion, and preservation is important for RNA quality [13,
14]. However, unfortunately, we could not obtain detailed
information including ischemia time, interval from sample
collection to formalin fixation, and formalin fixation dura-
tion. Currently, we are planning to obtain the duration of
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Figure 2: Correlation between RNA quality indexes and NGS library yields. (a, b) Correlation between RINe and DV200 of all samples in
terms of amount of the 1st NGS library product per input (◇: fresh, ●: frozen, and ×: FFPE). NGS libraries were prepared using TruSeq
RNA Access or TruSight RNA Pan-Cancer. The amount of the 1st NGS library product was measured using Qubit. Threshold lines are
drawn for the amount of the 1st NGS library product (10 ng/ng) and the cutoff value (RINe: 2.3 and DV200: 66.1) on the basis of receiver
operating characteristic (ROC) curve analysis. (c)–(f) are segregated from all samples depending on sample type: fresh sample (◇: c, d) or
FFPE sample (×: e, f).
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processing for sample preservation to investigate the effect of
the duration of the preservation process on RNA quality as
well as NGS libraries.
5. Conclusion
The DV200 index is a more consistent assessment of the
amount of the 1st NGS library product per input than the
RINe index, especially for low-quality RNA. Therefore, we
conclude that the DV200 is a beneficial RNA quality index
for NGS analyses using degraded RNA samples such as those
extracted from FFPE samples.
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